Navigation Links
Neuralstem Updates ALS Clinical Trial Progress
Date:2/10/2011

euralstem's spinal cord stem cells in the treatment of ALS, the first FDA-approved ALS stem cell trial, has been underway since January, 2010. The trial plans to enroll up to 18 ALS patients, who will be examined at regular intervals post-surgery.

All of the first six patients treated in the trial were non-ambulatory. Of these, the first three received five injections each, unilaterally, in the lumbar region of the spinal cord. The next three patients received ten injections each, bilaterally in the lumbar region. All remaining trial patients are ambulatory, and therefore represent earlier stages of disease progression. Of the ambulatory group, the first three patients received five injections each, unilaterally, in the lumbar region. The next three, which have just been approved, will receive ten injections each, bilaterally, in the lumbar region. After the required FDA approval, the final six patients in the trial will receive injections in the cervical region.  

While the trial is evaluating only the safety of the cells and procedure, it includes exploratory endpoints including  attenuation of motor function loss, maintenance of respiratory capacity, and stabilization of patients along the ALS functional rating scale.

The Emory ALS Center has posted the relevant trial information for patients on its website at http://www.neurology.emory.edu/ALS/Stem%20Cell.html.  

About Neuralstem

Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. Neuralstem is in a FDA-approved Phase I safety clinical trial for amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's disease, which has been rewarded Orphan Drug Status
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
2. Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
3. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
4. Neuralstems ALS Trial on Clinical Hold
5. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
6. Neuralstem Announces Issuance of Core Technology Patent in Europe
7. K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva™
8. ISTA Pharmaceuticals Achieves 2010 Revenue and Earnings Guidance; Provides 2011 Financial Guidance and Updates Key Plans
9. Vista Partners Updates Coverage on Pro-Pharmaceuticals, Inc.; Maintains Target Price of $2.10
10. Access Pharmaceuticals Updates MuGard Website With First Patient Testimonial Video
11. Intercell AG Announces Q3 2010 Results and Updates on R&D Progress and Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Sept. 2, 2014 Astellas has appointed James ... (IP) in the Americas. Kellerman will report directly to ... counsel at Astellas. In his new role, Kellerman will ... the business and manage the region,s intellectual property matters, ... "I am very pleased to welcome Jim to Astellas. ...
(Date:9/2/2014)... Sept. 2, 2014  Numotion is pleased to announce the ... of Directors. Mark is a 30-year retired ... positions across the organization and was a GE Company Officer ... Mark spent many years running business units within GE Healthcare, ... Healthcare Americas. "We are delighted to welcome ...
(Date:9/2/2014)... Texas , Sept. 2, 2014  On July ... notice to Congress that it is moving forward to ... down the minutes until laboratories throughout the U.S. will ... Although some medical laboratories may subscribe to ... the FDA to put guidelines in place, it,s widely ...
Breaking Medicine Technology:Leading Intellectual Property Counsel, James Kellerman, Joins Astellas as Vice President 2FDA Tells Congress It Intends to Regulate LDTs! Web Conference to Provide Straight Talk on Essential Steps Clinical Laboratories and Pathology Groups Will Need to Take to Comply 2FDA Tells Congress It Intends to Regulate LDTs! Web Conference to Provide Straight Talk on Essential Steps Clinical Laboratories and Pathology Groups Will Need to Take to Comply 3
... Today, Siemens (NYSE: SI ) announces the appointment ... Officer (CMIO), of the Health Services (HS) Business Unit. One ... Health Information Exchange (IHIE), Marc recently served as the President ... Siemens, Marc will be responsible for clinical informatics activities and ...
... Minn., Feb. 21, 2011 Acuo Technologies®, a ... the medical imaging industry for archiving, collaboration and ... of the latest release of its market leading ... significant enterprise capabilities including cloud-enablement, workflow services, and ...
Cached Medicine Technology:Siemens Appoints Overhage as New Chief Medical Informatics Officer 2Acuo Technologies Announces New Enterprise Capabilities with Latest Software Release 2
(Date:9/2/2014)... 03, 2014 Recently, Top 10 ... companies and announced that JustHost ( http://www.justhost.com/track/seohosts ) ... webmasters. , “The hosting suppliers we recommend are ... competitors on hosting features, uptime and server speed ... Best SEO Hosting says. “We believe that BlueHost ...
(Date:9/2/2014)... The exciting information sessions and AMTC ... Carey Lewis and Bob Wiley. The team of ... have the desire to illuminate entertainment with the light ... be invited to join the Bridge Training Program ... Saturday, Sept. 6, Charlotte Convention Center, 501 South College ...
(Date:9/2/2014)... Washington, DC (PRWEB) September 02, 2014 TCG, ... named by Inc. 5000 as one of the fastest-growing companies ... the eighth time total. TCG was previously recognized in 2013, ... 2001. , TCG’s revenue has grown 86% from 2010 to ... of the fastest growing businesses in America - up 635 ...
(Date:9/2/2014)... 02, 2014 Friendship Village of ... “This creates a contemporary marketing presence and ... its parent organization, Friendship Senior Options,” said Stephen ... Options. “By changing the logo, we are making ... to seniors and their families.” , Friendship Village ...
(Date:9/2/2014)... September 02, 2014 Cloud Medical Doctor ... “Cloud Based” Medical Practice Business Operations solutions and Billing ... Digital Cyber Security solutions for all industries announced today ... the trading floor of the CME in Chicago by ... stated that we are very proud of the recognition ...
Breaking Medicine News(10 mins):Health News:Actors, Models and Talent for Christ Auditions Are Set for Charlotte and Omaha on Saturday, September 6, 2014 2Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Friendship Village of Schaumburg In Illinois Announces New Logo 2Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 2Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 3
... the recent economic downturn, natural health degree ... still experiencing a wellness boom, as holistic ... the Internet,s top natural health career site ... training, chiropractic, nutrition, Reiki and reflexology career ...
... Upsher-Smith announces the launch of www.prenexa.com , a web site ... with more plant-based DHA (docosahexaenoic acid) than any other prenatal vitamin. ... ... Upsher-Smith announces the launch of prenexa.com, a web site devoted to ...
... from the Dutch Health Insurance System model, according to an ... of the Journal of Health Politics, Policy and Law ... at The University of Texas School of Public Health at ... coverage in the Netherlands and its possible lessons for the ...
... prevention and treatment for people living with HIV/AIDS. , ... ... annual World AIDS Day , global health activists gathered for ... today that nearly 6,000 people from 163 countries signed a petition ...
... SAN FRANCISCO, Dec. 8 Quantros, a leading ... healthcare industry, today,announced that the Agency for Healthcare ... Quantros Patient Safety Center as a Patient Safety,Organization ... . The Quantros Patient Safety Center,is a new ...
... iron from the heart in beta-thalassemia patients with mild to severe ... a subgroup analysis of 341 patients with myelodysplastic syndromes (MDS), Exjade ... -These results are part of the largest prospective trial ... transfusion-dependent anemias , , EAST HANOVER, ...
Cached Medicine News:Health News:Natural Healers Researches Natural Health Careers to Make the Prospective Holistic Health Students' Job Easier 2Health News:Natural Healers Researches Natural Health Careers to Make the Prospective Holistic Health Students' Job Easier 3Health News:Upsher-Smith Laboratories Launches Prenexa.com to Support Prenatal Nutrition and Health 2Health News:Upsher-Smith Laboratories Launches Prenexa.com to Support Prenatal Nutrition and Health 3Health News:UT public health policy expert says US can learn from Dutch universal health-care coverage 2Health News:Thousands Sign Petition for Action on HIV/AIDS and Malaria 2Health News:Thousands Sign Petition for Action on HIV/AIDS and Malaria 3Health News:Thousands Sign Petition for Action on HIV/AIDS and Malaria 4Health News:Quantros Patient Safety Center Receives Certification as a Patient Safety Organization (PSO) 2Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 2Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 3Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 4Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 5Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 6Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 7Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 8Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 9
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: